Provided by Tiger Trade Technology Pte. Ltd.

Helmerich & Payne

43.55
-0.5500-1.25%
Post-market: 43.550.00000.00%19:30 EDT
Volume:928.58K
Turnover:40.56M
Market Cap:4.35B
PE:-31.36
High:44.90
Open:44.33
Low:43.28
Close:44.10
52wk High:45.00
52wk Low:17.98
Shares:99.85M
Float Shares:95.92M
Volume Ratio:0.98
T/O Rate:0.97%
Dividend:1.00
Dividend Rate:2.29%
EPS(TTM):-1.3888
EPS(LYR):-1.6630
ROE:-4.64%
ROA:0.94%
PB:1.69
PE(LYR):-26.19

Loading ...

Chinese Manufacturers Projected to Retain Over 30% of Global Notebook Production Share in 2026, Despite Shifting Market Dynamics

Stock News
·
52 mins ago

What Is HP (HPQ) Signaling With Its New Push Into Gaming Gear?

Simply Wall St.
·
Yesterday

First Gas from Australia's Beetaloo Puts Shale Ambition to the Test

Reuters
·
Aug 21

Helmerich & Payne Price Target Raised to $41.00/Share from $36.00 by Morgan Stanley

Dow Jones
·
Aug 21

Helmerich & Payne price target raised to $41 from $36 at Morgan Stanley

TIPRANKS
·
Aug 20

Don't Ignore The Insider Selling In Helmerich & Payne

Simply Wall St.
·
Aug 20

Morgan Stanley Adjusts Price Target on Helmerich & Payne to $41 From $36, Keeps Underweight Rating

MT Newswires Live
·
Aug 20

Analysts Conflicted on These Technology Names: HP (HPQ) and Analog Devices (ADI)

TIPRANKS
·
Aug 20

HP Likely to Post Personal Systems Revenue Beat in Fiscal Q3, Bank of America Securities Says

MT Newswires Live
·
Aug 19

Helmerich & Payne Executives Make Bold Moves in Major Insider Stock Sales

TIPRANKS
·
Aug 19

Helmerich & Payne VP, CAO Sara Marie Momper Sells 5,054 Shares Worth $223,791.12

Reuters
·
Aug 19

HP Adhesives Publishes Unaudited Q1 FY27 Results, Reinforces SEBI-Compliant Disclosure

TIPRANKS
·
Aug 15

HP Inc. Stock Slides 3.8%, Underperforms Peers

Dow Jones
·
Aug 15

HP Inc. Stock Advances 6.9%, Outperforms Peers

Dow Jones
·
Aug 14

Easton Biopharmaceuticals Enrolls First Subject in HP-002 Tablets Clinical Trial

MT Newswires Live
·
Aug 13

Helmerich & Payne EVP Michael Lennox Disposes of 5,000 Common Shares Worth $200,000

Reuters
·
Aug 13

Marc Bianchi Raises HP Target to $49 but Maintains Hold as Risk‑Reward Turns More Balanced

TIPRANKS
·
Aug 13

Goldman Sachs Adjusts Price Target on HP to $21 From $19, Maintains Sell Rating

MT Newswires Live
·
Aug 12

Chengdu Easton Biopharma Subsidiary Initiates Phase I/II Trial for Novel Lymphoma Drug, First Patient Dosed

Stock News
·
Aug 12

H&P Releases Transcript of Fiscal Q3 2026 Earnings Call

Reuters
·
Aug 11